Roy K. Malkin is Officer of Subsidiary at CANTEL MEDICAL CORP (CMN). They have made 5 open-market trades across 1 company since 2007, most recently 2011-10-29.
CIK 0001244408
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CMN | 59,921 | $4.9M |
Shares reported on the most recent Form 4, priced at the 2011-11-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMN | SELL | 2010-12-17 | 2010-12-21 | $23.84 | $644K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2010-01-05 | 2010-01-07 | $20.84 | $229K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2009-06-08 | 2009-06-10 | $16.16 | $137K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2009-03-17 | 2009-03-19 | $14.21 | $114K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2007-10-10 | 2007-10-11 | $16.95 | $424K | -7.1% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.